Description

Sermorelin + GHRP-2 Blend Vials

Sermorelin + GHRP-2 Blend contains 5mg of Sermorelin and 5mg GHRP-2, totaling 10mg.

Sermorelin
CAS Number	86168-78-7
Molar Mass	3357.93 g·mol−1
Chemical Formula	C149H246N44O42S
IUPAC Name	L-Tyrosyl-L-alanyl-L-α-aspartyl-L-alanyl-L-isoleucyl-L-phenylalanyl-L-threonyl-L-asparaginyl-L-seryl-L-tyrosyl-L-arginyl-L-lysyl-L-valyl-L-leucylglycyl-L-glutaminyl-L-leucyl-L-seryl-L-alanyl-L-arginyl-L-lysyl-L-leucyl-L-leucyl-L-glutaminyl-L-α-aspartyl-L-isoleucyl-L-methionyl-L-seryl-L-argininamide

GHRP-2
CAS Number	158861-67-7
Molar Mass	817.992 g·mol−1
Chemical Formula	C45H55N9O6
IUPAC Name	(2S)-6-Amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide

Introduction

The Sermorelin + GHRP-2 Blend is a research peptide formulation carefully crafted for scientific investigation. With a focus on growth-related processes, this blend combines the properties of Sermorelin and GHRP-2 for researchers seeking to explore their potential synergies and specific benefits in the realm of growth and muscle development.

Key Characteristics

Sermorelin is recognized for its ability to stimulate the release of growth hormone, Sermorelin is a key component contributing to the growth-related focus of this research blend. GHRP-2 is known for its growth hormone-releasing properties, GHRP-2 complements Sermorelin, enhancing the blend’s capacity for research into growth and muscle-related processes.

Research Applications

The Sermorelin + GHRP-2 Blend is specifically designed for researchers investigating growth-related processes, exploring potential synergies between Sermorelin and GHRP-2, and studying applications related to muscle growth.

Research Benefits

Potential for Synergistic Benefit

Researchers are encouraged to explore the combined effects of Sermorelin and GHRP-2, assessing potential synergies in growth-related processes.

Sermorelin and Testosterone

Studies may delve into the relationship between Sermorelin and testosterone, providing insights into potential hormonal interactions.

GHRP-2 May Improve Muscle Growth

The blend offers a platform for research into the muscle growth-enhancing properties of GHRP-2, contributing to a deeper understanding of its effects.

Summary

The Sermorelin + GHRP-2 Blend serves as a valuable research tool for scientific exploration into growth-related processes, potential synergies, and muscle growth. Researchers can leverage this blend to gain insights into the combined effects of Sermorelin and GHRP-2.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Chatelain PG, Sanchez P, Saez JM. Growth hormone and insulin-like growth factor I treatment increase testicular luteinizing hormone receptors and steroidogenic responsiveness of growth hormone deficient dwarf mice. Endocrinology. 1991 Apr;128(4):1857-62. doi: 10.1210/endo-128-4-1857. PMID: 2004605. [Read More].
2. Hu R, Wang Z, Peng Q, Zou H, Wang H, Yu X, et al. (2016) Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation. PLoS ONE 11(2): e0149461. https://doi.org/10.1371/journal.pone.0149461. [Read More].